Zusammenfassung
Einleitung
Die Myokarditis ist eine schwer zu diagnostizierende Erkrankung, bei der das Risiko der Entwicklung einer dilatativen Kardiomyopathie und für den plötzlichen Herztod besteht.
Methoden und Patienten
In dieser Untersuchung wurden 102 Patienten, die bei Diagnose oder Verdachtsdiagnose einer Myokarditis im Department für Innere Medizin des Universitätsklinikums Halle (Saale) von 2003 bis 2013 behandelt worden waren, eingeschlossen.
Resultate
77,5 % der Studienteilnehmer waren männlich. Im Durchschnitt waren die Patienten 35,5 ± 14,1 Jahre alt. Als Symptome wurden in 46,1 % der Fälle Angina pectoris, in 38,2 % Dyspnoe, in 29,4 % Leistungsabfall, in 9,8 % Palpitationen und in 8,8 % Synkopen angegeben. Bei 45,1 % der Patienten ging ein Atemwegsinfekt voraus. Alle Patienten erhielten eine Echokardiographie, wobei sich bei 20,4 % ein Perikarderguss und bei 36,5 % Wandbewegungsstörungen nachweisen ließen. Eine Myokardbiopsie erfolgte bei 15,6 % der Patienten. Auf kardiotrope Viren wurde bei 37,3 % untersucht und bei 5,9 % der Gesamtgruppe nachgewiesen. Eine kardiale Magnetresonanztomographie (cMRT) erhielten 82 der Patienten, wobei sich in 33,3 % der Fälle ein „late enhancement“ und bei 11,9 % eine Wandbewegungsstörung zeigten. In dieser Studie verstarben 4 Patienten, alle männlich, 3 weitere erlitten eine erneute Myokarditis (Ende der Datenerhebung: September 2013).
Schlussfolgerung
In dieser Arbeit konnte die Symptombreite einer Myokarditis dargestellt werden. Eine Myokarditis manifestiert sich selten durch schwere Verläufe, in dieser Studie lag die Letalität bei 3,9 %. Für die weitere Optimierung der Diagnose- und Behandlungsalgorithmen wären prospektive, randomisierte Studien wünschenswert.
Abstract
Introduction
Myocarditis is a disease which is difficult to diagnose and which includes a risk of the development of dilated cardiomyopathy and sudden cardiac death.
Methods and patients
In this study 102 patients were included from the time period 2003–2013 after diagnosis or suspected diagnosis of myocarditis in the department of internal medicine at the University Hospital Halle (Saale).
Results
Of the study participants 77.5% were male and the average age was 35.5 ± 14.1 years. The symptoms reported by the patients were angina in 46.1%, dyspnea in 38.2%, performance deterioration in 29.4%, palpitations in 9.8% and syncope in 8.8%. In 45.1% of patients, symptoms were preceded by a respiratory infection. All patients underwent an echocardiogram and in 36.5% it was possible to demonstrate a regional wall motion abnormality and in 20.4% a pericardial effusion. A myocardial biopsy was performed in 15.6% of the patients. The presence of cardiotropic viruses was investigated in 37.3% of patients but was detected in only 5.9%. Cardiac magnetic resonance imaging (MRI) was performed in 82 patients of whom 33.3% showed a late enhancement and 11.9% a wall movement disorder. In this study four patients, all male, died and three suffered recurrent myocarditis.
Conclusion
This study showed the wide range of symptoms in myocarditis. Myocarditis is rarely severely manifested and in this study the mortality was 3.9%. For further optimization of the diagnostic and treatment algorithms, prospective, randomized studies would be desirable.
Literatur
Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93(5):841–842. doi:10.1161/01.CIR.93.5.841
Marin-Neto JA, Cunha-Neto E, Simoes MV (2007) Pathogenesis of chronic chagas heart disease. Circulation 115:1109–1123. doi:10.1161/CIRCULATIONAHA.106.624296
Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL et al (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895. doi:10.1161/01.CIR.99.7.889
Kandolf R (2004) Virus etiology of inflammatory cardiomyopathy. Dtsch Med Wochenschr 129:2187–2192. doi:10.1055/s-2004-831863
Frustaci A, Calabrese F, Chimenti C, Pieroni M et al (2002) Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest 122:1348–1356. doi:10.1378/chest.122.4.1348
Fung G, Luo H, Qiu Y, Yang D, McManus B (2016) Myocarditis. Circ Res 118:496–514. doi:10.1161/CIRCRESAHA.115.306573
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648. doi:10.1093/eurheartj/eht210 (2648a–2648 d)
Constanzo-Nordin MR, O’Connell JB, Subramanian R, Robinson JA et al (1985) Myocarditis confirmed by biopsy presenting as acute myocardial infarction. Br Heart J 53(1):25–29. doi:10.1136/hrt.53.1.25
Abelmann WH, Lorell BH (1989) The challenge of cardiomyopathy. J Am Coll Cardiol 13:1219–1239. doi:10.1016/0735-1097(89)90293-3
Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331:1564–1575. doi:10.1056/NEJM199505183322015
Schwartzkopff B, Klein RM, Strauer BE (1995) Diagnostik und Therapie der Myokarditis. Internist 36:469–483
Gravanis MB, Sternby NH (1991) Incidence of myocarditis. A 10-year autopsy study from Malmö, Sweden. Arch Pathol 115(4):390–399
Fabre A, Sheppard MN (2005) Sudden death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 92(3):316–320. doi:10.1136/hrt.2004.045518
Drory Y, Turetz Y, Hiss Y, Lev B et al (1991) Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 68:1388–1392. doi:10.1016/0002-9149(91)90251-F
Friman G, Wesslen L (2000) Special feature for the olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes. Immunol Cell Biol 78:510–522. doi:10.1111/j.1440-1711.2000.t01-12-.x
Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:1422–1445. doi:10.1093/eurheartj/ehi325
Peters NS, Poole-Wilson PA (1991) Myocarditis continuing clinical and pathologic confusion. Am Heart J 121:942–947. doi:10.1016/0002-8703(91)90221-3
Spodick DH, Greene TO, Saperia G (1995) Images in cardiovascular medicine. Acute myocarditis masquerading as acute myocardial infarction. Circulation 91:1886–1887. doi:10.1161/01.CIR.91.6.1886
Bultmann BD, Klingel K, Sotlar K, Bock CT et al (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease:an endothelial cell-mediated disease. Hum Pathol 34:92–95. doi:10.1053/hupa.2003.48
Celik T, Selimov N, Isik E (2006) Prognostic significance of electrocardiographic abnormalities in diphtheritic myocarditis after hospital discharge: a long term follow up. Ann Noninvasive Electrocardiol 11(1):28–33. doi:10.1111/j.1542-474X.2006.00062.x
Lauer B, Niederau C, Kühl U, Schannwell M et al (1997) Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 30:1354–1359. doi:10.1016/S0735-1097(97)00317-3
Smith SC, Ladenson JH, Mason JW, Jaffe AS (1997) Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95:163–168. doi:10.1161/01.CIR.95.1.163
Naparstek Y, Poltz PH (1993) The role of autoantibodies in autoimmune diseases. Annu Rev Immunol 11:79–104. doi:10.1146/annurev.iy.11.040193.000455
Mangin M, Mahrholdt H, Sechtem U (2006) Diagnosis of myocarditis: description and assessment of available methods. Dtsch Med Wochenschr 131:1228–1234. doi:10.1055/s-2006-941758
Cooper LT, Baughman KL, Feldman AM, Frustaci A et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 28:3076–3093. doi:10.1016/j.jacc.2007.09.008
Schultheiss HP, Kuehl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32:2616–2665. doi:10.1093/eurheartj/ehr165
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG et al (2015) ESC guidelines for the management of infective endocarditis. Eur Heart J 36(44):3075–3128. doi:10.1093/eurheartj/ehv319
Phillips M, Robinowitz M, Higgins JR, Boran KJ et al (1986) Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 256:2696–2699. doi:10.1001/jama.1986.03380190066026
McCaffrey FM, Braden DS, Strong WB (1991) Sudden cardiac death in young athletes. A review. Am J Dis Child 145:177–183. doi:10.1001/archpedi.1991.02160020069020
Wesslen L, Pahlson C, Lindquist O, Hjelm E et al (1996) An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979–1992. Eur Heart J 17(902):902–910
Robert Koch-Institut (2010) Myokarditis, Reihe Gesundheitsberichterstattung des Bundes, Diagnosedaten der Krankenhäuser ab 2000 (Eckdaten der vollstationären Patienten und Patientinnen). Gliederungsmerkmale: Jahre, Behandlungs-/Wohnort, ICD10 (Primärquelle: Statistisches Bundesamt, Mikrozensus). http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/&p_aid=i&p_aid=19746165&nummer=550&p_sprache=D&p_indsp=-&p_aid=24749302. Zugegriffen: 14. Dez 2014
Hufnagel G, Pankuweit S, Richter A, Schonian U et al (2000) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 25(3):279–285. doi:10.1007/s000590050021
Cooper LT (2009) Myocarditis, medical progress. N Engl J Med 360:1526–1538. doi:10.1056/NEJMra0800028
Pinamonti B, Alberti E, Cigalotto A, Dreas L et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–291. doi:10.1016/0002-9149(88)90226-3
Hunold P, Schlosser T, Vogt FM, Eggebrecht H et al (2005) Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 184:1420–1426. doi:10.2214/ajr.184.5.01841420
Aretz HT, Billingham ME, Edwards WD (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1(1):3–14
Dec GW, Palacios IF, Fallon JT, Aretz HT et al (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates and clinical outcome. N Engl J Med 312:885–890. doi:10.1056/NEJM198504043121404
Kühl U, Pauschinger M, Seeberg B, Lassner D et al (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970. doi:10.1161/CIRCULATIONAHA.105.548156
Koide H, Kitaura Y, Deguchi H, Ukimura A et al (1992) Genomic detection of enteroviruses in the myocardium: studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn Circ J 52:1081–1093. doi:10.1253/jcj.56.1081
Grasso M, Arbustini E, Silini E, Diegoli M et al (1992) Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 69:658–664. doi:10.1016/0002-9149(92)90160-Z
Maisch B, Hufnagel G, Schonian U, Hengstenberg C (1995) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). Eur Heart J 16(Suppl O):173–175. doi:10.1093/eurheartj/16.suppl_O.
Osterziel KJ, Dietz R (1997) Therapie der Herzinsuffizienz mit ß‑Blockern. Z Kardiol 86:1–8. doi:10.1007/PL00007336
Burch GE, Giles TD (1972) Prolonged bed rest in the management of patients with cardiomyopathy. Cardiovasc Clin 4(1):375–387
D’Ambrosio A, Patti G, Manzoli A, Sinagra G et al (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85(5):499–504. doi:10.1136/heart.85.5.499
Magnani JW, Danik HJ, Dec GW, Jared W et al (2006) Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 151(2):463–470. doi:10.1016/j.ahj.2005.03.037
McCarthy RE, Boehmer JP, Hrubran RH (2000) Longterm outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695. doi:10.1056/NEJM200003093421003
Why HJF, Meany BT, Richardson PJ, Olson EGJ et al (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89:2582–2258. doi:10.1161/01.CIR.89.6.2582
Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–1398. doi:10.1056/NEJM200011093431908
Caforio AL, Calabrese F, Angelini A (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:1326–1333. doi:10.1093/eurheartj/ehm076
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Streuber, F. Noack, D. Stoevesandt und A. Schlitt geben an, dass kein Interessenkonflikt besteht.
Alle beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zuständigen Ethik-Kommission, im Einklang mit nationalem Recht sowie gemäß der Deklaration von Helsinki von 1975 (in der aktuellen, überarbeiteten Fassung) durchgeführt. Von allen beteiligten Patienten liegt eine Einverständniserklärung vor.
Rights and permissions
About this article
Cite this article
Streuber, S., Noack, F., Stoevesandt, D. et al. 102 Patienten mit Verdacht auf Myokarditis. Herz 43, 69–77 (2018). https://doi.org/10.1007/s00059-016-4524-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-016-4524-3